BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30369534)

  • 21. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.
    Tu XK; Fujimura M; Rashad S; Mugikura S; Sakata H; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):507-512. PubMed ID: 28357585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
    Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
    Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-operative hemorrhage due to hyperperfusion during direct revascularization surgery in an adult patient with moyamoya disease: a case report.
    Uchida H; Endo H; Fujimura M; Endo T; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Oct; 40(4):679-684. PubMed ID: 28600750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo ivy sign indicates postoperative hyperperfusion in moyamoya disease.
    Horie N; Morikawa M; Morofuji Y; Hiu T; Izumo T; Hayashi K; Nagata I
    Stroke; 2014 May; 45(5):1488-91. PubMed ID: 24713526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient Global Cerebral Hypoperfusion as a Characteristic Cerebral Hemodynamic Pattern in the Acute Stage after Combined Revascularization Surgery for Pediatric Moyamoya Disease: N-Isopropyl-P-[123I] Iodoamphetamine Single-Photon Emission Computed Tomography Study.
    Kanoke A; Fujimura M; Tashiro R; Ozaki D; Tominaga T
    Cerebrovasc Dis; 2022; 51(4):453-460. PubMed ID: 34933301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors of Delayed Hyperperfusion and the Importance of Repeated Cerebral Blood Flow Evaluation for Hyperperfusion After Direct Bypass for Moyamoya Disease.
    Nomura S; Yamaguchi K; Ishikawa T; Kawashima A; Okada Y; Kawamata T
    World Neurosurg; 2018 Oct; 118():e468-e472. PubMed ID: 29990604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.
    Sato K; Yamada M; Kuroda H; Yamamoto D; Asano Y; Inoue Y; Fujii K; Kumabe T
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1244-8. PubMed ID: 26939637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease.
    Zhao WG; Luo Q; Jia JB; Yu JL
    Br J Neurosurg; 2013 Jun; 27(3):321-5. PubMed ID: 23461748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De Novo Cerebral Microbleeds and Cognitive Decline in Cerebral Hyperperfusion After Direct Revascularization for Adult Moyamoya Disease.
    Dobashi K; Kubo Y; Kimura K; Katakura Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Ogasawara K
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106166. PubMed ID: 34768143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive assessment of cerebral microvascular changes for predicting postoperative cerebral hyperperfusion after surgical revascularisation for moyamoya disease: an arterial spin labelling MRI study.
    Agarwal V; Singh P; Ahuja CK; Gupta SK; Aggarwal A; Narayanan R
    Neuroradiology; 2021 Apr; 63(4):563-572. PubMed ID: 33098435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.
    Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T
    Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease.
    Kazumata K; Tha KK; Uchino H; Shiga T; Shichinohe H; Ito M; Nakayama N; Abumiya T
    J Neurosurg; 2017 Aug; 127(2):260-269. PubMed ID: 27588593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristic Pattern of the Cerebral Hemodynamic Changes in the Acute Stage After Combined Revascularization Surgery for Adult Moyamoya Disease: N-isopropyl-p-[
    Fujimura M; Tominaga T
    Acta Neurochir Suppl; 2021; 132():57-61. PubMed ID: 33973029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic cerebral hyperperfusion on SPECT after indirect revascularization surgery for Moyamoya disease.
    Cho WS; Lee HY; Kang HS; Kim JE; Bang JS; Oh CW
    Clin Nucl Med; 2013 Jan; 38(1):44-6. PubMed ID: 23242046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matching Selection of Donor-Recipient Vessels in Revascularization Surgery Effectively Reduce the Incidence of Postoperative Hyperperfusion Syndrome in Adult Moyamoya Disease: A Retrospective Comparison Study.
    ; Zeng X; Su K; Tian X; Chen J;
    Cerebrovasc Dis; 2020; 49(4):361-368. PubMed ID: 32674110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.